Sezione III civile; sentenza 9 maggio 1967, n. 934; Pres. Boccia P., Est. Sbrocca, P. M. Toro (concl. conf.); Soc. Liquigas (Avv. Guerra) c. Celi (Avv. Pacifici); Celi c. Soc. Liquigas

Publikováno v: Il Foro Italiano, 1967 Jul 01. 90(7/8), 1487/1488-1491/1492.

Externí odkaz: https://www.jstor.org/stable/23157006

Uptake of Risk-Reducing Salpingo-Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers.

Autor: Inzoli A; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Negri S; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Dell'Oro C; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Costa C; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Marchetta L; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Boccadutri M; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Fumagalli S; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Roversi G; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Medical Genetics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Sala EM; Medical Genetics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Celi C; Clinical Psychology Unit, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy., Rossi V; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Fruscio R; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Gynecology Unit, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy.

Publikováno v: Cancer medicine [Cancer Med] 2024 Dec; Vol. 13 (23), pp. e70321.

Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial.

Autor: Nawrocki ST; Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, Arizona., Olea J; Division of Hematology, Health Sciences Campus, University of Southern California, Los Angeles, California., Villa Celi C; Division of Hematology, Health Sciences Campus, University of Southern California, Los Angeles, California., Dadrastoussi H; Division of Hematology, Health Sciences Campus, University of Southern California, Los Angeles, California., Wu K; Division of Hematology, Health Sciences Campus, University of Southern California, Los Angeles, California., Tsao-Wei D; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Colombo A; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Coffey M; Oncolytics Biotech, Inc, Calgary, Alberta, Canada., Fernandez Hernandez E; Division of Hematology, Health Sciences Campus, University of Southern California, Los Angeles, California., Chen X; Division of Hematology, Health Sciences Campus, University of Southern California, Los Angeles, California., Nuovo GJ; The Ohio State University Comprehensive Cancer Center Columbus, Columbus, Ohio., Carew JS; Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, Arizona., Mohrbacher AF; Division of Hematology, Health Sciences Campus, University of Southern California, Los Angeles, California., Fields P; Formerly, Adaptive Biotechnologies, Seattle, Washington; currently, Tempus Labs, Seattle, Washington., Kuhn P; USC Michelson Center for Convergent Biosciences and Department of Biological Sciences, University of Southern California, Los Angeles., Siddiqi I; Department of Pathology, University of Southern California, Los Angeles, California., Merchant A; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Kelly KR; Division of Hematology, Health Sciences Campus, University of Southern California, Los Angeles, California.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 15; Vol. 29 (24), pp. 5087-5103.

Zigomicose nasofacial: relato de um caso do estado do Pará, Brasil Nasofacial zygomycosis: case report from Pará, Brazil

Autor: Mário A. P. Moraes, Margarida M. R. Almeida, Regina Celi C. Veiga, Fernando T. Silveira

Publikováno v: Revista do Instituto de Medicina Tropical de São Paulo, Vol 36, Iss 2, Pp 171-174 (1994)

Um caso de zigomicose nasofacial, causado por Conidiobolus coronatus, é descrito em paciente de 64 anos, do sexo feminino, procedente de Barcarena, Estado do Pará. Trata-se de doença rara na Região Norte do país - a maioria dos casos brasileiros

Externí odkaz: https://doaj.org/article/313df32dd552490a9c0423fe163b22eb

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.